Therapeutic effect of adipose derived mesenchymal stem cell for neonatal brain injury
Project/Area Number |
25860908
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Embryonic/Neonatal medicine
|
Research Institution | Nagoya University |
Principal Investigator |
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2014: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 間葉系幹細胞 / 安全性 / 新生児低酸素性虚血性脳症 / 安全性確認 |
Outline of Final Research Achievements |
Neonatal hypoxyic ischemic encephalopathy is the main cause of cerebral palsy. We investigated the therapeutic effect of adipose-derived mesenchymal stem cell (ASC). However, administration of ASC has no effect on brain injury, and caused pulmonary embolism and hemorrhage.
|
Report
(4 results)
Research Products
(4 results)